{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:57:26Z","timestamp":1782284246950,"version":"3.54.5"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.dsx.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T16:45:42Z","timestamp":1499532342000},"page":"S841-S851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S2","title":["Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination"],"prefix":"10.1016","volume":"11","author":[{"given":"SB","family":"JAVN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhiya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Sundari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchana","family":"Mala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"issue":"6A","key":"10.1016\/j.dsx.2017.07.004_bib0010","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1016\/S0002-9343(98)00184-3","article-title":"Biologic markers as predictors of cardiovascular disease","volume":"104","author":"Frishman","year":"1998","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2459\/JCM.0b013e32830b58d4","article-title":"Cardiovascular risk in women with polycystic ovary syndrome","volume":"9","author":"Giallauria","year":"2008","journal-title":"J Cardiovas Med"},{"issue":"18","key":"10.1016\/j.dsx.2017.07.004_bib0030","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2174\/1381612822666160216151852","article-title":"Oxidative stress in polycystic ovary syndrome","volume":"22","author":"Papalou","year":"2016","journal-title":"Cur Pharm Des"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"issue":"6865","key":"10.1016\/j.dsx.2017.07.004_bib0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2017.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","article-title":"Protein glycation, diabetes, and aging","volume":"56","author":"Ulrich","year":"2001","journal-title":"Recent Prog Horm Res"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/B:REMD.0000032406.84813.f6","article-title":"Glycoxidation and diabetic complications: modern lessons and a warning?","volume":"5","author":"Vlassara","year":"2004","journal-title":"Rev Endocrin Metab Disord"},{"key":"10.1016\/j.dsx.2017.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/dc05-2096","article-title":"Diabetes and advanced glycoxidation end products","volume":"29","author":"Huebschmann","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2017.07.004_bib0060","doi-asserted-by":"crossref","first-page":"F645","DOI":"10.1152\/ajprenal.00398.2004","article-title":"Advanced glycation end products and the kidney","volume":"289","author":"Bohlender","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.dsx.2017.07.004_bib0065","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1016\/S0021-9258(17)44682-5","article-title":"Nonenzymatic glycosylation and glucose-dependent cross-linking of proteins","volume":"258","author":"Eble","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dsx.2017.07.004_bib0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/dmrr.233","article-title":"The AGE-receptor in the pathogenesis of diabetic complications","volume":"17","author":"Vlassara","year":"2001","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.dsx.2017.07.004_bib0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.dsx.2017.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Merhi Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","author":"Pertynska-Marczewska","year":"2015","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0085","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","article-title":"Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries","volume":"127","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","article-title":"RAGE: a novel biological and genetic marker for vascular disease","volume":"116","author":"Kalea","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.dsx.2017.07.004_bib0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00109-009-0439-2","article-title":"Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response","volume":"87","author":"Yan","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.dsx.2017.07.004_bib0110","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.1016\/S0021-9258(18)42287-9","article-title":"Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin\/type IV collagen","volume":"267","author":"Haitoglou","year":"1992","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14310\/horm.2002.1320","article-title":"Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?","volume":"10","author":"Christakou","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0120","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.ATV.14.10.1521","article-title":"Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions","volume":"14","author":"Schmidt","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.dsx.2017.07.004_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2000-8471","article-title":"Biological and environmental determinants of plasma homocysteine","volume":"26","author":"Schneede","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0021-9150(75)90004-0","article-title":"Homocysteine theory of arteriosclerosis","volume":"22","author":"McCully","year":"1975","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1005377310872","article-title":"Putative mechanisms for vascular damage by homocysteine","volume":"20","author":"Bellamy","year":"1997","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0155","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.CIR.96.8.2542","article-title":"Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans","volume":"96","author":"Woo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2017.07.004_bib0160","first-page":"197","article-title":"Insulin resistance is associated with elevated plasma total homocysteine levels in healthy non-obese subjects","volume":"139","author":"Giltay","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2017.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2337\/diacare.23.9.1348","article-title":"Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents","volume":"23","author":"Gallistl","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(02)03247-8","article-title":"Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss","volume":"78","author":"Craig","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389200052997393","article-title":"Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction","volume":"6","author":"St\u00fchlinger","year":"2005","journal-title":"Curr Drug Metab"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (pcos): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0185","doi-asserted-by":"crossref","first-page":"e0157389","DOI":"10.1371\/journal.pone.0157389","article-title":"Association between high serum homocysteine levels and biochemical characteristics in women with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2017.07.004_bib0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000058367","article-title":"The plasma homocysteine levels are increased in polycystic ovary syndrome","volume":"53","author":"Loverro","year":"2002","journal-title":"Gynecol Obstet Invest"},{"issue":"1-2","key":"10.1016\/j.dsx.2017.07.004_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","article-title":"The role of nitric oxide in cardiovascular diseases","volume":"26","author":"Naseem","year":"2005","journal-title":"Mol Asp Med"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0200","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12272-009-1801-1","article-title":"Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases","volume":"32","author":"Napoli","year":"2009","journal-title":"Arch Pharm Res"},{"issue":"37","key":"10.1016\/j.dsx.2017.07.004_bib0205","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1021\/bi00088a020","article-title":"NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase","volume":"32","author":"Olken","year":"1993","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0210","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0008-6363(03)00500-5","article-title":"The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor","volume":"59","author":"B\u00f6ger","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.dsx.2017.07.004_bib0215","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-201x.1999.00587.x","article-title":"Regulation of macrophage nitric oxide synthesis by endothelial cells: a role for NG, NG-dimethylarginine","volume":"167","author":"Fickling","year":"1999","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1567-5688(03)00033-3","article-title":"ADMA and oxidative stress","volume":"4","author":"Sydow","year":"2003","journal-title":"Atheroscler Suppl"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0235","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.fertnstert.2008.10.073","article-title":"Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters","volume":"93","author":"Pamuk","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2017.07.004_bib0245","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","article-title":"von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes","volume":"117","author":"Spiel","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/1050-1738(94)90023-X","article-title":"Molecular and cellular biology of von Willebrand factor","volume":"4","author":"Lyons","year":"1994","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0255","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0260","first-page":"362","article-title":"Von Willebrand\u2019s factor and von Willebrand\u2019s disease","volume":"1","author":"Matsushita","year":"1994","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0265","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1160\/TH06-02-0079","article-title":"Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin","volume":"95","author":"G\u00f3mez-Ambrosi","year":"2006","journal-title":"Thromb Haemost"},{"issue":"9588","key":"10.1016\/j.dsx.2017.07.004_bib0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03401540","article-title":"Plasma von Willebrand factor antigen levels are elevated in the classicphenotypes of polycystic ovary syndrome","volume":"11","author":"Koiou","year":"2012","journal-title":"Hormones (Athens)"},{"issue":"22","key":"10.1016\/j.dsx.2017.07.004_bib0280","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","article-title":"von Willebrand factor and coronary heart disease: prospective study and meta-analysis","volume":"23","author":"Whincup","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2017.07.004_bib0285","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.108.792986","article-title":"Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study","volume":"118","author":"Frankel","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ahj.2013.11.012","article-title":"Vitamin D deficiency and coronary artery disease: a review of the evidence","volume":"167","author":"Kunadian","year":"2014","journal-title":"Am Heart J"},{"issue":"23","key":"10.1016\/j.dsx.2017.07.004_bib0300","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/eurheartj\/ehr459","article-title":"Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress","volume":"33","author":"Dong","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0305","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00404-009-0958-7","article-title":"Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome","volume":"280","author":"Yildizhan","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0310","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0315","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0320","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1210\/jc.2010-2212","article-title":"Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes","volume":"96","author":"Yiu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0325","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1570161114666161003093443","article-title":"Hypo-vitaminosis D is associated with endothelial dysfunction in patients with metabolic syndrome","volume":"15","author":"Oruc","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3343\/alm.2014.34.2.98","article-title":"Mean platelet volume and vitamin D level","volume":"34","author":"Cure","year":"2014","journal-title":"Ann Lab Med"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/2042018816653357","article-title":"Effect of vitamin D supplementation on cardiovascular disease riskfactors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study","volume":"7","author":"Al-Dujaili","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.004_bib0340","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCULATIONAHA.108.846725","article-title":"Predicting the development of atherosclerosis","volume":"119","author":"Steffel","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0345","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2008.02.034","article-title":"Impaired endothelial function in C-reactive protein overexpressing mice","volume":"201","author":"Teoh","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0350","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.ATV.0000126681.16619.69","article-title":"C-reactive protein does not directly induce tissue factor in human monocytes","volume":"24","author":"Paffen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.0000130484.20501.df","article-title":"C-reactive protein: risk marker or mediator in atherothrombosis?","volume":"44","author":"Jialal","year":"2004","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.dsx.2017.07.004_bib0360","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s11745-005-1488-8","article-title":"Overview of hemostatic factors involved in atherosclerotic cardiovascular disease","volume":"40","author":"Kannel","year":"2005","journal-title":"Lipids"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0365","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","article-title":"C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant","volume":"25","author":"Singh","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0370","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0375","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/j.2040-4603.2016.tb00731.x","article-title":"Adipose tissue-derived plasminogen activator inhibitor-1 function and regulation","volume":"6","author":"Kaji","year":"2016","journal-title":"Compr Physiol"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0380","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1467-789X.2002.00056.x","article-title":"Obesity, haemostasis and the fibrinolytic system","volume":"3","author":"Mertens","year":"2002","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0390","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1157\/13119918","article-title":"Adipocytokines: implications in the prognosis and drug treatment of cardiovascular diseases","volume":"208","author":"Iglesias-Osma","year":"2008","journal-title":"Rev Clin Esp"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0395","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1079\/PNS2005428","article-title":"Secretory factors from human adipose tissue and their functional role","volume":"64","author":"Hauner","year":"2005","journal-title":"Proc Nutr Soc"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.004_bib0400","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0031-1277226","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes","volume":"43","author":"Li","year":"2011","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0405","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: coagulopathy","volume":"173","author":"Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1079\/BJN20041213","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0415","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"issue":"1-2","key":"10.1016\/j.dsx.2017.07.004_bib0420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(94)90933-4","article-title":"Penetration of interleukin-6 across the murine blood-brain barrier","volume":"179","author":"Banks","year":"1994","journal-title":"Neurosci Lett"},{"issue":"Pt 1","key":"10.1016\/j.dsx.2017.07.004_bib0425","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signaling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.dsx.2017.07.004_bib0430","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0083-6729(08)00621-3","article-title":"Interleukin-6 and insulin resistance","volume":"80","author":"Kim","year":"2009","journal-title":"Vitam Horm"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0435","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0404.2008.01068.x","article-title":"Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease","volume":"119","author":"Koutouzis","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0440","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","article-title":"Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor","volume":"94","author":"Wassmann","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.dsx.2017.07.004_bib0445","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.12659\/MSM.894926","article-title":"Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus metformin","volume":"21","author":"Sun","year":"2015","journal-title":"Med Sci Monit"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0450","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/abbs\/gmt085","article-title":"Jagged-1\/Notch3 signaling transduction pathway is involved in apelin-13- induced vascular smooth muscle cells proliferation","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0455","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2353\/ajpath.2007.070471","article-title":"Requirement of apelin\u2013apelin receptor system for oxidative stress-linkedatherosclerosis","volume":"171","author":"Hashimoto","year":"2007","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0460","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/abbs\/gmq035","article-title":"PI3 K\/Akt signaling transduction pathway is involved in rat vascularsmooth muscle cell proliferation induced by apelin-13","volume":"42","author":"Liu","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.dsx.2017.07.004_bib0465","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.2741\/2967","article-title":"Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1","volume":"13","author":"Li","year":"2008","journal-title":"Front Biosci"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0470","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","article-title":"Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation","volume":"94","author":"Plati","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0475","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2012.03.056","article-title":"Adipose expression of adipocytokines in women with polycystic ovary syndrome","volume":"98","author":"Svendsen","year":"2012","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0480","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/B:JARG.0000046204.81682.67","article-title":"Serum leptin elevation in obese women with PCOS: a continuing controversy","volume":"21","author":"Saleh","year":"2004","journal-title":"J Assist Reprod Genet"},{"issue":"5290","key":"10.1016\/j.dsx.2017.07.004_bib0485","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.274.5290.1185","article-title":"Modulation of insulin activities by leptin","volume":"274","author":"Cohen","year":"1996","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.dsx.2017.07.004_bib0490","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0495","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1210\/jc.2003-031676","article-title":"Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes","volume":"89","author":"Reilly","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0500","doi-asserted-by":"crossref","first-page":"H48","DOI":"10.1152\/ajpheart.01159.2004","article-title":"Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction","volume":"289","author":"Knudson","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0505","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1253\/circj.CJ-09-0534","article-title":"Non-invasive vascular function tests: their pathophysiological background and clinical application","volume":"74","author":"Tomiyama","year":"2010","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0510","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2006.02.010","article-title":"Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease","volume":"188","author":"Gable","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0515","first-page":"20","article-title":"Hypoadiponectinemia: a risk factor for metabolic syndrome","volume":"41","author":"Renaldi","year":"2009","journal-title":"Acta Med Indones"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0520","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","article-title":"Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0525","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2003-030219","article-title":"Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in non-obese women with polycystic ovary","volume":"88","author":"Ducluzeau","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1160\/TH08-02-0124","article-title":"Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells","volume":"100","author":"Chen","year":"2008","journal-title":"Thromb Haemost"},{"issue":"22","key":"10.1016\/j.dsx.2017.07.004_bib0535","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0540","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0004-27302009000200005","article-title":"Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis","volume":"53","author":"Wajchenberg","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2017.07.004_bib0545","doi-asserted-by":"crossref","first-page":"946427","DOI":"10.1155\/2013\/946427","article-title":"Visfatin\/Nampt: an adipokine with cardiovascular impact","volume":"2013","author":"Romacho","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0550","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/09513590.2015.1056140","article-title":"High-visfatin levels in women with polycystic ovary syndrome: evidence from a metaanalysis","volume":"31","author":"Sun","year":"2015","journal-title":"Gynecol Endocrinol."},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0555","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3892\/etm.2014.1556","article-title":"Plasma visfatin levels and mRNA expression of visfatin in peripheral blood mononuclear cells and peripheral blood monocyte-derived macrophages from normal weight females with polycystic ovary syndrome","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0560","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpag.2014.08.007","article-title":"Plasma visfatin levels in adolescents with polycystic ovary syndrome: a prospective case-control study","volume":"28","author":"G\u00fcm\u00fc\u015f","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0565","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.2011.04171.x","article-title":"Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome","volume":"76","author":"Pepene","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0570","first-page":"160","article-title":"New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer)","volume":"38","author":"Tjokroprawiro","year":"2006","journal-title":"Acta Med Indones"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0575","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1684\/ecn.2015.0370","article-title":"Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome","volume":"26","author":"Gul","year":"2015","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0580","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.0000084503.91330.49","article-title":"Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0585","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2006.08.052","article-title":"Resistin worsens cardiac ischaemia-reperfusion injury","volume":"349","author":"Rothwell","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0590","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2015.05.007","article-title":"Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome","volume":"104","author":"Sarray","year":"2015","journal-title":"Fertil Steril."},{"key":"10.1016\/j.dsx.2017.07.004_bib0595","doi-asserted-by":"crossref","first-page":"8589318","DOI":"10.1155\/2016\/8589318","article-title":"Roles of oxidative stress in polycystic ovary syndrome and cancers","volume":"2016","author":"Zuo","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0600","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.dsx.2017.07.004_bib0605","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0891-5849(00)00218-5","article-title":"Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB","volume":"28","author":"Janssen-Heininger","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10623320490482637","article-title":"The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis","volume":"11","author":"Kawashima","year":"2004","journal-title":"Endothelium"},{"issue":"16","key":"10.1016\/j.dsx.2017.07.004_bib0615","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.M413493200","article-title":"Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium","volume":"280","author":"He","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0620","first-page":"RA194","article-title":"Angiotensin II and vascular inflammation","volume":"11","author":"Cheng","year":"2005","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0625","doi-asserted-by":"crossref","first-page":"H1850","DOI":"10.1152\/ajpheart.00502.2011","article-title":"Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism","volume":"301","author":"Ishida","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0630","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Mill\u00e1n","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0635","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4067\/S0716-97602000000200008","article-title":"Endothelial cell oxidative stress and signal transduction","volume":"33","author":"Foncea","year":"2000","journal-title":"Biol Res"},{"issue":"15","key":"10.1016\/j.dsx.2017.07.004_bib0640","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/01.CIR.0000091407.86925.7A","article-title":"Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness","volume":"108","author":"Durier","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0645","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/01.CIR.0000056762.69302.46","article-title":"Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation","volume":"107","author":"Spiekermann","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0650","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0655","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0660","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3906\/sag-1401-4","article-title":"Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome","volume":"44","author":"Ta\u015flipinar","year":"2014","journal-title":"Turk J Med Sci"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0665","first-page":"31","article-title":"Status of homocysteine in polycystic ovary syndrome (PCOS)","volume":"8","author":"Maleedhu","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0670","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0675","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0680","first-page":"179","article-title":"Cortisol Testosterone ratio and homocysteine levels in patients with acute myocardial infarction","volume":"21","author":"Mujawar","year":"2010","journal-title":"Biomed Res"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0685","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.110.225326","article-title":"Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation","volume":"107","author":"Iwasaki","year":"2010","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0690","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humrep\/deg190","article-title":"Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine","volume":"18","author":"Schachter","year":"2003","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0695","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.2007.03021.x","article-title":"Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation","volume":"68","author":"Catal\u00e1n","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0700","doi-asserted-by":"crossref","first-page":"H903","DOI":"10.1152\/ajpheart.00936.2010","article-title":"Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism","volume":"301","author":"Karuppiah","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0705","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijgo.2007.09.019","article-title":"Plasminogen activator and plasma activator inhibitor-1 in young women with polycystic ovary syndrome","volume":"100","author":"Lin","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0710","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0715","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2007.09.006","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells","volume":"122","author":"Chen","year":"2008","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.dsx.2017.07.004_bib0720","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages. Implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.dsx.2017.07.004_bib0725","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2174\/138161207780831338","article-title":"C-reactive protein and asymmetric dimethylarginine: markers or mediators in cardiovascular disorders?","volume":"13","author":"Smith","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0730","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimar\u00e3es","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0735","doi-asserted-by":"crossref","first-page":"e0151960","DOI":"10.1371\/journal.pone.0151960","article-title":"Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase","volume":"11","author":"Victor","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0740","doi-asserted-by":"crossref","first-page":"e0148531","DOI":"10.1371\/journal.pone.0148531","article-title":"Interleukin-6 levels in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0745","first-page":"28","article-title":"ffects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency","volume":"36","author":"Rahimi-Ardabili","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0750","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2265.1992.tb02299.x","article-title":"Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery","volume":"37","author":"Kautzky-Willer","year":"1992","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0755","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03401540","article-title":"Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome","volume":"11","author":"Koiou","year":"2012","journal-title":"Hormones"},{"key":"10.1016\/j.dsx.2017.07.004_bib0760","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-12-9","article-title":"Ethinylestradiol30 (g-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?","volume":"12","author":"Ilie","year":"2012","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.004_bib0765","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","article-title":"Inflammatory and endothelial markers in women with polycystic ovary syndrome","volume":"36","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0770","first-page":"64","article-title":"The polycystic ovary syndrome [PCOS] status and cardiovascular risk in young women","volume":"6","author":"Ilie","year":"2010","journal-title":"Cent Eur J Med"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0775","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","article-title":"Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial","volume":"95","author":"Agarwal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0780","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","article-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","volume":"93","author":"Teede","year":"2008","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0785","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0790","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.004_bib0795","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2007.12.054","article-title":"Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS","volume":"200","author":"Ozgurtas","year":"2008","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.004_bib0800","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","article-title":"Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes","volume":"51","author":"Asagami","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2017.07.004_bib0805","doi-asserted-by":"crossref","first-page":"107e","DOI":"10.4172\/2155-6156.1000107e","article-title":"Old drug acquires new target: metformin and SIRT1","volume":"2","author":"Bashmakov","year":"2011","journal-title":"J Diabetes Metab"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0810","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbrc.2009.10.033","article-title":"Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells","volume":"390","author":"Scalera","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10.1016\/j.dsx.2017.07.004_bib0815","first-page":"30841","article-title":"Caveolin1\/protein arginine methyltransferase1\/sirtuin1 axis as a potential target against endothelial dysfunction","volume":"S1043-6618","author":"Charles","year":"2017","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.004_bib0820","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/nu5072475","article-title":"Metformin lowers serum cobalamin without changing other markers of cobalamin status: a study on women with polycystic ovary syndrome","volume":"5","author":"Greibe","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0825","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11739-014-1157-5","article-title":"The role of metformin on vitamin B12 deficiency: a meta-analysis review","volume":"10","author":"Niafar","year":"2015","journal-title":"Intern Emerg Med"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.004_bib0830","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.rbmo.2009.06.005","article-title":"Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS","volume":"19","author":"Kaya","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.004_bib0835","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study","volume":"101","author":"Aroda","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"31","key":"10.1016\/j.dsx.2017.07.004_bib0840","doi-asserted-by":"crossref","first-page":"28299","DOI":"10.1074\/jbc.M501971200","article-title":"Physiological regulation of phospholipid methylation alters plasma homocysteine in mice","volume":"280","author":"Jacobs","year":"2005","journal-title":"J Biol Chem"},{"issue":"5677","key":"10.1016\/j.dsx.2017.07.004_bib0845","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/275219a0","article-title":"Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity","volume":"275","author":"Hirata","year":"1978","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.dsx.2017.07.004_bib0850","doi-asserted-by":"crossref","first-page":"22403","DOI":"10.1074\/jbc.M110.108514","article-title":"Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity","volume":"285","author":"Jacobs","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.004_bib0855","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCRESAHA.110.238691","article-title":"Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-\/- mice","volume":"108","author":"Cole","year":"2011","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.dsx.2017.07.004_bib0860","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd3318","article-title":"Vitamin D, disease and therapeutic opportunities","volume":"9","author":"Plum","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0865","doi-asserted-by":"crossref","first-page":"e0151845","DOI":"10.1371\/journal.pone.0151845","article-title":"Cardiovascular protective effect of metformin and telmisartan: reduction of PARP1 activity via the AMPK-PARP1 cascade","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.004_bib0870","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.004_bib0875","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2017.07.004_bib0880","doi-asserted-by":"crossref","first-page":"56","DOI":"10.17987\/jatamis.v1i0.332","article-title":"Statins plus metformin: a promising combination for prevention and treatment of atherosclerosis","volume":"1","author":"Luo","year":"2016","journal-title":"J ATAMIS"},{"issue":"19","key":"10.1016\/j.dsx.2017.07.004_bib0885","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.CIR.0000065601.83526.3E","article-title":"Rosuvastatin decreases Caveolin-1 and improves Nitric Oxide-Dependent heart rate and blood pressure variability in Apolipoprotein E-\/- mice in vivo","volume":"107","author":"Pelat","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.004_bib0890","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1073\/pnas.95.3.1301","article-title":"Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy","volume":"95","author":"Corman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dsx.2017.07.004_bib0895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejogrb.2015.05.005","article-title":"Oxidative stress and cardiovascular complications in polycystic ovarian syndrome","volume":"191","author":"Hyderali","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117301650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117301650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:06:41Z","timestamp":1761728801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117301650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":179,"alternative-id":["S1871402117301650"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2017.07.004","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}